Jeong SH, Jang JH, Lee YB. Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. J Pharm Investig. 2023;53(1):119–52. https://doi.org/10.1007/s40005-022-00589-5.
Lee DV, Shen AM, Garbuzenko OB, Minko T. Liposomal formulations of anti-alzheimer drugs and sirna for nose-to-brain delivery: design, safety and efficacy in vitro. AAPS J. 2024;26(5):17. https://doi.org/10.1208/s12248-024-00967-x.
Mardikasari SA, Katona G, Csóka I. Serum albumin in nasal drug delivery systems: exploring the role and application. Pharmaceutics. 2024;16(10):17. https://doi.org/10.3390/pharmaceutics16101322.
Wang M, Ma XY, Zong SY, Su YQ, Su R, Zhang H, et al. The prescription design and key properties of nasal gel for CNS drug delivery: A review. Eur J Pharm Sci. 2024;192:22. https://doi.org/10.1016/j.ejps.2023.106623.
Nakahashi-Ouchida R, Fujihashi K, Kurashima Y, Yuki Y, Kiyono H. Nasal vaccines: solutions for respiratory infectious diseases. Trends Mol Med. 2023;29(2):124–40. https://doi.org/10.1016/j.molmed.2022.10.009.
Shrewsbury SB. The upper nasal space: option for systemic drug delivery, mucosal vaccines and “nose-to-brain.” Pharmaceutics. 2023;15(6):26. https://doi.org/10.3390/pharmaceutics15061720.
Xu D, Song XJ, Chen X, Wang JW, Cui YL. Advances and future perspectives of intranasal drug delivery: A scientometric review. J Control Release. 2024;367:366–84. https://doi.org/10.1016/j.jconrel.2024.01.053.
Article CAS PubMed Google Scholar
Aref ZF, Bazeed SEES, Hassan MH, Hassan AS, Rashad A, Hassan RG, et al. Clinical, biochemical and molecular evaluations of ivermectin mucoadhesive nanosuspension nasal spray in reducing upper respiratory symptoms of mild COVID-19. Int J Nanomed. 2021;16:4063–72. https://doi.org/10.2147/ijn.S313093.
Yu Y-S, AboulFotouh K, Xu H, Williams G, Suman J, Cano C, et al. Feasibility of intranasal delivery of thin-film freeze-dried, mucoadhesive vaccine powders. Int J Pharm. 2023;640:122990. https://doi.org/10.1016/j.ijpharm.2023.122990.
Article CAS PubMed Google Scholar
Baldelli A, Boraey MA, Oguzlu H, Cidem A, Rodriguez AP, Ong HX, et al. Engineered nasal dry powder for the encapsulation of bioactive compounds. Drug Discov Today. 2022;27(8):2300–8. https://doi.org/10.1016/j.drudis.2022.04.012.
Article CAS PubMed Google Scholar
Trenkel M, Scherließ R. Nasal powder formulations: in-vitro characterisation of the impact of powders on nasal residence time and sensory effects. Pharmaceutics. 2021;13(3):14. https://doi.org/10.3390/pharmaceutics13030385.
Puri V, Kaur VP, Singh A, Singh C. Recent advances on drug delivery applications of mucopenetrative/mucoadhesive particles: A review. J Drug Deliv Sci Technol. 2022;75:25. https://doi.org/10.1016/j.jddst.2022.103712.
Muntu CM, Avanti C, Hayun, Surini S. Promising brain biodistribution of insulin via intranasal dry powder for nose-to-brain delivery. Heliyon. 2024;10(13):16. https://doi.org/10.1016/j.heliyon.2024.e33657.
Mieda S, Inoue K, Ito A, Yada S, Miyajima M, Fukami T. Evaluation of the usefulness of hydroxypropyl cellulose and sucrose in the nasal influenza vaccine. J Drug Deliv Sci Technol. 2022;69:8. https://doi.org/10.1016/j.jddst.2022.103165.
Cama ES, Catenacci L, Perteghella S, Sorrenti M, Caira MR, Rassu G, et al. Design and development of a chitosan-based nasal powder of dimethyl fumarate-cyclodextrin binary systems aimed at nose-to-brain administration. A stability study Int J Pharm. 2024;659:14. https://doi.org/10.1016/j.ijpharm.2024.124216.
Fasiolo LT, Manniello MD, Tratta E, Buttini F, Rossi A, Sonvico F, et al. Opportunity and challenges of nasal powders: Drug formulation and delivery. Eur J Pharm Sci. 2018;113:2–17. https://doi.org/10.1016/j.ejps.2017.09.027.
Deruyver L, Rigaut C, Lambert P, Haut B, Goole J. The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery. Adv Drug Deliv Rev. 2021;175:23. https://doi.org/10.1016/j.addr.2021.113826.
Lombardo R, Ruponen M, Rautio J, Lampinen R, Kanninen KM, Koivisto AM, et al. A technological comparison of freeze-dried poly-ε-caprolactone (PCL) and poly (lactic-co-glycolic acid) (PLGA) nanoparticles loaded with clozapine for nose-to-brain delivery. J Drug Deliv Sci Technol. 2024;93:16. https://doi.org/10.1016/j.jddst.2024.105419.
Gavini E, Rassu G, Ferraro L, Generosi A, Rau JV, Brunetti A, et al. Influence of chitosan glutamate on the in vivo intranasal absorption of rokitamycin from microspheres. J Pharm Sci. 2011;100(4):1488–502. https://doi.org/10.1002/jps.22382.
Article CAS PubMed Google Scholar
Dalpiaz A, Gavini E, Colombo G, Russo P, Bortolotti F, Ferraro L, et al. Brain uptake of an anti-ischemic agent by nasal administration of microparticles. J Pharm Sci. 2008;97(11):4889–903. https://doi.org/10.1002/jps.21335.
Article CAS PubMed Google Scholar
Dalpiaz A, Fogagnolo M, Ferraro L, Capuzzo A, Pavan B, Rassu G, et al. Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries. Antiviral Res. 2015;123:146–57. https://doi.org/10.1016/j.antiviral.2015.09.013.
Article CAS PubMed Google Scholar
Fasiolo LT, Manniello MD, Bortolotti F, Buttini F, Rossi A, Sonvico F, et al. Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease. J Drug Target. 2019;27(9):984–94. https://doi.org/10.1080/1061186x.2019.1574300.
Wong SN, Li S, Low KH, Chan HW, Zhang XY, Chow S, et al. Development of favipiravir dry powders for intranasal delivery: An integrated cocrystal and particle engineering approach via spray freeze drying. Int J Pharm. 2024;653:16. https://doi.org/10.1016/j.ijpharm.2024.123896.
Varga P, Németh A, Zeiringer S, Roblegg E, Budai-Szűcs M, Balla-Bartos C, et al. Formulation and investigation of differently charged (3-cyclodextrin-based meloxicam potassium containing nasal powders. Eur J Pharm Sci. 2024;202:11. https://doi.org/10.1016/j.ejps.2024.106879.
Trenkel M, Scherließ R. Optimising nasal powder drug delivery - Characterisation of the effect of excipients on drug absorption. Int J Pharm. 2023;633:10. https://doi.org/10.1016/j.ijpharm.2023.122630.
Nižić L, Potaś J, Winnicka K, Szekalska M, Erak I, Gretić M, et al. Development, characterisation and nasal deposition of melatonin-loaded pectin/hypromellose microspheres. Eur J Pharm Sci. 2020;141:11. https://doi.org/10.1016/j.ejps.2019.105115.
Van Der Zwaan I, Franek F, Fransson R, Tehler U, Frenning G. Characterization of membrane-type dissolution profiles of clinically available orally inhaled products using a weibull fit and a mechanistic model. Mol Pharm. 2022;19(9):3114–24. https://doi.org/10.1021/acs.molpharmaceut.2c00177.
Article CAS PubMed PubMed Central Google Scholar
Amini E, Kurumaddali A, Bhagwat S, Berger SM, Hochhaus G. Optimization of the transwell® system for assessing the dissolution behavior of orally inhaled drug products through in vitro and in silico approaches. Pharmaceutics. 2021;13(8):21. https://doi.org/10.3390/pharmaceutics13081109.
Kumar V, Sethi B, Yanez E, Leung DH, Ghanwatkar YYY, Cheong JAT, et al. Effect of magnesium stearate surface coating method on the aerosol performance and permeability of micronized fluticasone propionate. Int J Pharm. 2022;615:13. https://doi.org/10.1016/j.ijpharm.2022.121470.
Papakyriakopoulou P, Manta K, Kostantini C, Kikionis S, Banella S, Ioannou E, et al. Nasal powders of quercetin-β-cyclodextrin derivatives complexes with mannitol/lecithin microparticles for Nose-to-Brain delivery: In vitro and ex vivo evaluation. Int J Pharm. 2021;607:10. https://doi.org/10.1016/j.ijpharm.2021.121016.
Perkušić M, Nodilo LN, Ugrina I, Špoljarić D, Brala CJ, Pepić I, et al. Tailoring functional spray-dried powder platform for efficient donepezil nose-to-brain delivery. Int J Pharm. 2022;624:15. https://doi.org/10.1016/j.ijpharm.2022.122038.
Comments (0)